Article Details
Retrieved on: 2019-04-04 08:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>8 analysts out of 10 Wall Street brokerage <b>firms</b> rate Intersect ENT, <b>Inc</b>. (NASDAQ:XENT) as a Buy, while 0 see it as a Sell. The rest 2 describe it as a ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here